Pancreatic Cancer Research

ResearcherNagoya City UniversityActive in the last 2 years

Shuji Takiguchi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1339-354X; OpenAlex author ID A5034428643, A5121276416. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 13)
Trials
0
Grants
0
Labs led
1
Collaborators
23
Papers, trials and grants by year

2018: 2 papers · 2019: 2 papers · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: 2 papers · 2024: 2 papers · 2025: 1 paper · 2026: 2 papers

Papers 14

  1. Interleukin-1 receptor type 1 in pancreatic cancer progression and metastasis: a review. Last author DOI 10.1007/s10147-026-03000-7↗
  2. Kaempferol Inhibits MMP-1-Mediated Migration and Invasion in Gemcitabine-Resistant Pancreatic Cancer Cells. Last author DOI 10.3390/nu18030380↗
  3. The Natural Compound CalebinA Suppresses Gemcitabine Resistance and Tumor Progression by Inhibiting Angiogenesis and Invasion Through NF-κB Signaling in Pancre… Last author DOI 10.3390/nu17162641↗
  4. Expression of ZKSCAN3 protein suppresses proliferation, migration, and invasion of pancreatic cancer through autophagy. Last author DOI 10.1111/cas.16173↗
  5. The Natural Product Parthenolide Inhibits Both Angiogenesis and Invasiveness and Improves Gemcitabine Resistance by Suppressing Nuclear Factor κB Activation in… Last author DOI 10.3390/nu16050705↗
  6. Upregulation of integrin‑linked kinase enhances tumor progression in gemcitabine‑resistant pancreatic cancer. Last author DOI 10.3892/or.2023.8601↗
  7. Girdin regulates both migration and angiogenesis in pancreatic cancer cell lines. Last author DOI 10.3892/or.2023.8606↗
  8. 10Z‑Hymenialdisine inhibits angiogenesis by suppressing NF‑κB activation in pancreatic cancer cell lines. Last author DOI 10.3892/or.2022.8259↗
  9. Enhanced CXCL12/CXCR4 signaling increases tumor progression in radiation‑resistant pancreatic cancer. Last author DOI 10.3892/or.2022.8279↗
  10. Escin inhibits angiogenesis by suppressing interleukin‑8 and vascular endothelial growth factor production by blocking nuclear factor‑κB activation in pancreat… Last author DOI 10.3892/or.2021.8006↗
  11. Acquisition of gemcitabine resistance enhances angiogenesis via upregulation of IL‑8 production in pancreatic cancer. Last author DOI 10.3892/or.2019.7105↗
  12. [A Case of Conversion Surgery for an Initially Locally Advanced Unresectable Pancreatic Cancer after S-1 Chemotherapy]. Last author PMID 32156996↗
  13. Xanthohumol inhibits angiogenesis by suppressing nuclear factor-κB activation in pancreatic cancer. Last author DOI 10.1111/cas.13441↗
  14. Case of pancreatic metastasis from colon cancer in which cell block using the Trefle® endoscopic scraper enables differential diagnosis from pancreatic cancer. Co-author DOI 10.4251/wjgo.v10.i3.91↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yoichi Matsuo · 13 shared papers, 2018–2026 · strength 2.01
  2. Kenta Saito · 12 shared papers, 2018–2026 · strength 1.77
  3. Hiromichi Murase · 9 shared papers, 2022–2026 · strength 1.65
  4. Tomokatsu Kato · 9 shared papers, 2021–2026 · strength 1.53
  5. Hiroki Takahashi · 11 shared papers, 2018–2025 · strength 1.49
  6. Keisuke Nonoyama · 7 shared papers, 2023–2026 · strength 1.38
  7. Yuki Denda · 7 shared papers, 2023–2026 · strength 1.38
  8. Hiroyuki Imafuji · 10 shared papers, 2018–2024 · strength 1.29
  9. Mamoru Morimoto · 10 shared papers, 2018–2024 · strength 1.29
  10. Yuichi Hayashi · 7 shared papers, 2019–2023 · strength 0.85
  11. Saburo Sugita · 4 shared papers, 2024–2026 · strength 0.80
  12. Yuki Eguchi · 4 shared papers, 2024–2026 · strength 0.80
  13. Kan Omi · 6 shared papers, 2019–2023 · strength 0.70
  14. Goro Ueda · 6 shared papers, 2019–2023 · strength 0.70
  15. Tomoya Shamoto · 1 shared paper, 2018 · strength 0.07
  16. Itaru Naitoh · 1 shared paper, 2018 · strength 0.07
  17. Yasuki Hori · 1 shared paper, 2018 · strength 0.07
  18. Naruomi Jinno · 1 shared paper, 2018 · strength 0.07
  19. Takashi Joh · 1 shared paper, 2018 · strength 0.07
  20. Michihiro Yoshida · 1 shared paper, 2018 · strength 0.07
  21. Hiroyuki Kato · 1 shared paper, 2018 · strength 0.07
  22. Akihisa Kato · 1 shared paper, 2018 · strength 0.07
  23. Satoru Takahashi · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.